📰 Path Stock Down News
Path Stock Down News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Path Stock Down. Real-time updates on events, politics, business and more.
May 30, 2024
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totalling 24,000 shares, a drop of 45.9% from the April 30th total of 44,400 shares. Currently, 1.5% of the company’s stock are short sold. Based on an […]
May 29, 2024
Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have received an average rating of “Moderate Buy” from the eighteen analysts that are covering the firm, Marketbeat.com reports. Nine investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month target price among […]
May 19, 2024
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital boosted their Q2 2024 earnings per share estimates for Bio-Path in a report released on Wednesday, May 15th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings per share of ($2.06) for the quarter, up from their previous estimate of ($4.60). […]
April 20, 2024
Powell Investment Advisors LLC bought a new position in shares of UiPath Inc. (NYSE:PATH – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,190 shares of the healthcare company’s stock, valued at approximately $402,000. Other institutional […]
April 3, 2024
UiPath Inc. (NYSE:PATH – Get Free Report)’s stock price traded up 0.2% during mid-day trading on Wednesday . The stock traded as high as $21.73 and last traded at $21.61. 1,595,202 shares were traded during mid-day trading, a decline of 83% from the average session volume of 9,332,723 shares. The stock had previously closed at […]
April 2, 2024
Shares of UiPath Inc. (NYSE:PATH – Get Free Report) were down 3% on Tuesday . The company traded as low as $21.30 and last traded at $21.52. Approximately 2,391,464 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 9,385,548 shares. The stock had previously closed at $22.19. Analysts […]
March 24, 2024
Truist Financial restated their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a $32.00 price target on the healthcare company’s stock. Other research analysts also recently issued reports about the stock. Bank of America increased their target price […]
February 18, 2024
Princeton Capital Management LLC boosted its stake in UiPath Inc. (NYSE:PATH – Free Report) by 16.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 16,367 shares of the healthcare company’s stock after purchasing an additional 2,356 shares during the period. Princeton Capital Management LLC’s holdings in UiPath were worth $280,000 as of […]
November 20, 2023
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the stock. Bio-Path Stock Down 1.9 % Shares of Bio-Path stock opened at $0.53 on Thursday. Bio-Path has a 12 month low of $0.32 and a 12 month high of $2.35. […]
November 17, 2023
UiPath Inc. (NYSE:PATH – Get Free Report) Director Rich Wong sold 100,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $18.07, for a total value of $1,807,000.00. Following the sale, the director now directly owns 756,599 shares of the company’s stock, valued […]